摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[COD]PtCl(bis(trimethylsilyl)amido)] | 1055933-99-7

中文名称
——
中文别名
——
英文名称
[COD]PtCl(bis(trimethylsilyl)amido)]
英文别名
(COD)PtCl(N(SiMe3)2);bis(trimethylsilyl)azanide;(1Z,5Z)-cycloocta-1,5-diene;platinum(2+);chloride
[COD]PtCl(bis(trimethylsilyl)amido)]化学式
CAS
1055933-99-7
化学式
C14H30ClNPtSi2
mdl
——
分子量
499.103
InChiKey
XLJWDVKWZZRJNS-PHFPKPIQSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    [COD]PtCl(bis(trimethylsilyl)amido)]1,3-双(二叔丁基膦甲基)苯氘代苯 为溶剂, 生成 (2,6-bis[(di-t-butylphosphino)methyl]phenyl)chloroplatinum
    参考文献:
    名称:
    铂(II)双(三甲基甲硅烷基)酰胺基络合物的合成:钳夹配体环金属化的一种较好的起始原料
    摘要:
    用LiN(SiMe 3)2处理[(COD)PtCl 2 ]可以得到高产率的[COD] PtClN(SiMe 3)2。该产品具有包括X射线结构在内的所有特征。从许多实施例中,它被证明是制备PXP铂金络合物的非常方便的起始原料,在温和条件下,环金属化产物的收率极高。
    DOI:
    10.1021/om800444g
  • 作为产物:
    描述:
    dichloro( 1,5-cyclooctadiene)platinum(ll)lithium hexamethyldisilazane乙醚正己烷 为溶剂, 以84%的产率得到[COD]PtCl(bis(trimethylsilyl)amido)]
    参考文献:
    名称:
    铂(II)双(三甲基甲硅烷基)酰胺基络合物的合成:钳夹配体环金属化的一种较好的起始原料
    摘要:
    用LiN(SiMe 3)2处理[(COD)PtCl 2 ]可以得到高产率的[COD] PtClN(SiMe 3)2。该产品具有包括X射线结构在内的所有特征。从许多实施例中,它被证明是制备PXP铂金络合物的非常方便的起始原料,在温和条件下,环金属化产物的收率极高。
    DOI:
    10.1021/om800444g
点击查看最新优质反应信息

文献信息

  • Carboxylation of pincer PCP platinum methoxide complexes under formation of metalla carbonates
    作者:Athimoolam Arunachalampillai、Nagarajan Loganathan、Ola F. Wendt
    DOI:10.1016/j.poly.2011.08.028
    日期:2012.1
    The ligand 2,6-bis[(diphenylphosphino)methyl]benzene ((PCP)H) was prepared and characterised in an improved manner. With platinum it forms the complex (PCP)PtOTf which reacts with sodium methoxide to give (PCP)PtOMe as the major product together with a small amount of [(PCP)Pt](2)-mu-H. The platinum methoxide reacts with carbon dioxide to give (PCP)PtO(CO)OMe. Also the dinuclear [(PCP)Pt](2)(mu-O(CO)OMe) is formed in this reaction if (PCP)PtOTf is present. The crystal structures for [(PCP)PtOH2]OTf, PCP)PtOMe, [(PCP)Pt](2)-mu-H and [(PCP)Pt](2)(mu-O(CO)OMe) are reported. (c) 2011 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

乙基6H-1,2-恶嗪-3-羧酸酯 6-乙氧基-6H-1,2-恶嗪-3-甲醛 6-乙氧基-3-苯基-6H-1,2-恶嗪 5-甲氧基-3,6-二氢-2H-[1,4]恶嗪 5-乙氧基-3,6-二氢-2H-1,4-恶嗪 5,6-二氢-2H-1,4-恶嗪-3-胺 4H-1,4-恶嗪 4-(叔丁氧羰基)-4H-[1,4]恶嗪 3H-咪唑并[2,1-c][1,4]恶嗪 3-甲基-5-苯基-2H-1,4-恶嗪 3,5-二苯基-2H-1,4-恶嗪 3,5,5,6-四甲基-5,6-二氢-2H-1,4-恶嗪-2-酮 2H-[1,4]恶嗪并[3,4-b][1,3]恶嗪 2H-1,4-恶嗪 2H-1,4-噁嗪-2-酮,5,6-二氢-5-(1-甲基乙基)-3-苯基-,(S)- 2H-1,4-噁嗪-2-酮,3-(1,1-二甲基乙基)-5,6-二氢-5-苯基-,(R)- 2H-1,3-恶嗪 2H-1,2-恶嗪 2-异丙基-4,4,6-三甲基-4H-1,3-恶嗪 2-(二甲基氨基)-4-苯基-4H-1,3-恶嗪-5-甲醛 2,4,4-三(三氟甲基)-6-全氟丁基-1,3,5-恶二嗪 (5S)-5,6-二氢-6,6-二甲基-5-苯基-2H-1,4-恶嗪-2-酮 3-(triethylsilyl)-2,5-dihydrofuran 4,4,6-trimethyl-2-propyl-4H-[1,3]oxazine 3-methyl-6,7,8,8a-tetrahydro-5H-cyclohepta[d]isoxazole 2,4-Dicyan-6-methyl-1,3-oxazepin 2,4-Dicyan-1,3-oxazepin 4-tert-Butyl-2,4,6-trimethyl-4H-pyran 3-(4,4,6-trimethyl-4H-[1,3]oxazin-2-yl)-propionitrile 4,4,6-Trimethyl-2-isopropenyl-1,3,4-oxazin 4a,7a-dihydro-4a,6-dimethyl-3-phenyl-4H-furo<2,3-e>-1,2-oxazine 3-methyl-1,4,6,9-tetraoxa-2-aza-5λ5-phospha-spiro[4.4]non-2-ene 6,8-Diethyl-1,1,2,2,3,3-hexafluoro-5-oxa-7,9-diaza-spiro[3.5]nona-6,8-diene (R)-4-Ethyl-3-((4S,5S)-4-methoxymethyl-5-phenyl-4,5-dihydro-oxazol-2-yl)-4H-pyridine-1-carboxylic acid methyl ester 4-Phenyl-2-pyrrolidin-1-yl-4,5-dihydro-furan-3-carbonitrile (S)-4-Ethyl-3-((4S,5S)-4-methoxymethyl-5-phenyl-4,5-dihydro-oxazol-2-yl)-4H-pyridine-1-carboxylic acid methyl ester (3S)-5-methyl-3-propan-2-yl-2,3-dihydro-1,4-oxazin-6-one dimethyl[η(10)-2,4-cyclopentadien-1-ylidene(dimethylsilylene)(3,4-di-tert-butyl-2,4-cyclopentadien-1-ylidene)]zirconium tert-butoxymethyl[η(10)-2,4-cyclopentadien-1-ylidene(dimethylsilylene)(3,4-di-tert-butyl-2,4-cyclopentadien-1-ylidene)]zirconium 2-Trimethylsilyl-4-methyl-4H-pyran methyl 3-methyl-6-trimethylsilylcyclohexa-1,4-dienecarboxylate 5-methyl-3-phenyl-(3ar,6ac)-3a,6a-dihydro-furo[2,3-d]isoxazole 2-methyl-4-chloro-3,6-dihydro-1,2-oxazine 4-n-butyl-3-<(N,N-diethylamino)methyl>-4,6-dimethyl-4H-pyran 3,5-diphenyl-(3ar,4at,7at,9ac)-3a,4a,7a,9a-tetrahydro-cyclohepta[2,1-d;4,5-d']diisoxazol-4-one 2-methyl-5-chloro-3,6-dihydro-1,2-oxazine 4,4-Di-tert-butyl-3-methyl-4H-<1,2>oxazet-N-oxid 6H-Pyrano[3,4-c]pyridine 6-ethoxy-3-phenyl-4-(trimethylsilylethynyl)-6H-1,2-oxazine 5,5-Dimethyl-2-oxazolin-4-spiro-3'-(1'-pyrrolin)